Research ArticleOriginal Article
Open Access

Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats

Impact on therapeutics

Ali M. Alshabi, Saad A. Alkahtani, Ibrahim A. Shaikh and Mohammed S. Habeeb
Saudi Medical Journal February 2021, 42 (2) 151-160; DOI: https://doi.org/10.15537/smj.2021.2.25695

References

  1. 1.↵
    1. Cornelis MC.
    The impact of caffeine and coffee on human health. Nutrients 2019; 11: 416.
    OpenUrl
  2. 2.↵
    1. Reyes CM,
    2. Cornelis MC.
    Caffeine in the diet: country-level consumption and guidelines. Nutrients 2018; 10: 1772.
    OpenUrl
  3. 3.↵
    1. Carlström M,
    2. Larsson SC.
    Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev 2018; 76: 395-417.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Gaeini Z,
    2. Bahadoran Z,
    3. Mirmiran P,
    4. Azizi F.
    Tea, coffee, caffeine intake and the risk of cardio-metabolic outcomes: findings from a population with low coffee and high tea consumption. Nutr Metab (Lond) 2019; 16: 28.
    OpenUrl
  5. 5.↵
    1. Rostas SE,
    2. McPherson C.
    Caffeine therapy in preterm infants: the dose (and timing) make the medicine. Neonatal Netw 2019; 38: 365-374.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    World Health Organization. World Health Organization Model List of Essential Medicines. [Updated 2019, Accessed 2020 December 13]. Available from URL: https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf
  7. 7.↵
    1. Cano-Marquina A,
    2. Tarín JJ,
    3. Cano A.
    The impact of coffee on health. Maturitas 2013; 75: 7-21.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Gupta RC,
    2. Chang D,
    3. Nammi S,
    4. Bensoussan A,
    5. Bilinski K,
    6. Roufogalis BD.
    Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr 2017; 9: 59.
    OpenUrl
  9. 9.↵
    1. Al-Majed A,
    2. Bakheit AH,
    3. Abdel Aziz HA,
    4. Alharbi H,
    5. Al-Jenoobi FI.
    Pioglitazone. Profiles Drug Subst Excip Relat Methodol 2016; 41: 379-438.
    OpenUrl
  10. 10.↵
    1. Tornio A,
    2. Niemi M,
    3. Neuvonen PJ,
    4. Backman JT.
    Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol Sci. 2012; 33: 312-322.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Mamindla S,
    2. Koganti VSRGP,
    3. Ravouru N,
    4. Koganti B.
    Effect of cinnamomum cassia on the pharmacokinetics and pharmacodynamics of pioglitazone. Curr Clin Pharmacol 2017; 12: 41-49.
    OpenUrl
  12. 12.↵
    1. Choi JS,
    2. Choi I,
    3. Choi DH.
    Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in rats. Eur J Drug Metab Pharmacokinet 2016; 41: 231-238.
    OpenUrl
  13. 13.↵
    1. Manitpisitkul P,
    2. Curtin CR,
    3. Shalayda K,
    4. Wang SS,
    5. Ford L,
    6. Heald D.
    Pharmacokinetic interactions between topiramate and pioglitazone and metformin. Epilepsy Res 2014; 108: 1519-1532.
    OpenUrl
  14. 14.↵
    1. Itkonen MK,
    2. Tornio A,
    3. Neuvonen M,
    4. Neuvonen PJ,
    5. Niemi M,
    6. Backman JT.
    Clopidogrel markedly increases plasma concentrations of CYP2C8 substrate pioglitazone. Drug Metab Dispos 2016; 44: 1364-1371.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Unasegaran T,
    2. Mustafa MR,
    3. Achike FI,
    4. Murugan DD.
    Quercetin and pioglitazone synergistically reverse endothelial dysfunction in isolated aorta from fructose-streptozotocin (F-STZ)-induced diabetic rats. Eur J Pharmacol 2017; 799: 160-170.
    OpenUrl
  16. 16.↵
    1. Jaakkola T,
    2. Backman JT,
    3. Neuvonen M,
    4. Laitila J,
    5. Neuvonen PJ.
    Effect of Gemfibrozil, Itraconazole and their combination on the pharmacokinetics of pioglitazone. Clin Pharmacol Ther 2005; 77: 404-414.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Deng LJ,
    2. Wang F,
    3. Li HD.
    Effect of gemfibrozil on the pharmacokinetics of pioglitazone. Eur J Clin Pharmacol 2005; 61: 831-836.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Alsheik-Ali AA,
    2. Karas RH.
    Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones. Am J Cardiol 2004; 93: 1417-1418, A9.
    OpenUrl
  19. 19.↵
    1. Al-Mssallem MQ,
    2. Brown JE.
    Arabic coffee increases the glycemic index but not insulinemic index of dates. Saudi Med J 2013; 34: 923-928.
    OpenUrl
  20. 20.↵
    International Diabetes Federation Prevalence of diabetes in Saudi Arabia. [Updated 2020 February 25. Accessed 2020 December 13]. Available at URL: https://idf.org/our-network/regions-members/middle-east-and-north-africa/members/46-saudi-arabia.html.
  21. 21.↵
    1. Bushra R,
    2. Aslam N,
    3. Khan AY.
    Food-drug interactions. Oman Med J. 2011; 26: 77-83.
    OpenUrlPubMed
  22. 22.↵
    1. Liu R,
    2. AbdulHameed MDM,
    3. Kumar K,
    4. Yu X,
    5. Wallqvist A.
    Data-driven prediction of adverse drug reactions induced by drug-drug interactions. BMC Pharmacol Toxicol 2017; 18: 44.
    OpenUrl
  23. 23.↵
    1. Hägg S,
    2. Spigset O,
    3. Mjörndal T,
    4. Dahlqvist R.
    Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2000; 49: 59-63.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Iqbal N,
    2. Ahmad B,
    3. Janbaz KH,
    4. Gilani AU,
    5. Niazi SK.
    The effect of caffeine on the pharmacokinetics of acetaminophen in man. Biopharm Drug Dispos 1995; 16: 481-487.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Gökcen BB,
    2. Şanlier N.
    Coffee consumption and disease correlations. Crit Rev Food Sci Nutr 2019; 59: 336-348.
    OpenUrl
  26. 26.↵
    1. Lamontagne J,
    2. Pepin E,
    3. Peyot ML,
    4. Joly E,
    5. Ruderman NB,
    6. Poitout V, et al.
    Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations. Endocrinology 2009; 150: 3465-3474.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Rezvani AH,
    2. Sexton HG,
    3. Johnson J,
    4. Wells C,
    5. Gordon K,
    6. Levin ED.
    Effects of caffeine on alcohol consumption and nicotine self-administration in rats. Alcohol Clin Exp Res 2013; 37: 1609-1617.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Furman BL.
    Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2015; 70: 5.47.1-5.47.20.
    OpenUrl
  29. 29.↵
    1. Farsi E,
    2. Ahmad M,
    3. Hor SY,
    4. Ahamed MB,
    5. Yam MF,
    6. Asmawi MZ, et al.
    Standardized extract of Ficus deltoidea stimulates insulin secretion and blocks hepatic glucose production by regulating the expression of glucose-metabolic genes in streptozitocin-induced diabetic rats. BMC Complement Altern Med. 2014; 14: 220. Erratum in: BMC Complement Altern Med 2018; 18: 262.
    OpenUrl
  30. 30.↵
    1. Qahtani MA,
    2. Shaikh IA,
    3. Habeeb MS.
    Hibiscus sabdariffa L. extract ameliorates the diabetic late complications: Cardioprotective and nephroprotective effect in streptozotocin-induced diabetic rats. Int J Green Pharm 2018; 11: S896.
    OpenUrl
  31. 31.↵
    1. Anwer MK,
    2. Mohammad M,
    3. Ezzeldin E,
    4. Fatima F,
    5. Alalaiwe A,
    6. Iqbal M.
    Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomedicine 2019; 14: 1587-1595.
    OpenUrl
  32. 32.↵
    1. Medina-López R,
    2. Vara-Gama N,
    3. Soria-Arteche O,
    4. Moreno-Rocha LA,
    5. López-Muñoz FJ.
    Pharmacokinetics and pharmacodynamics of (s)-ketoprofen co-administered with caffeine: a preclinical study in arthritic rats. Pharmaceutics 2018; 10: 20.
    OpenUrl
  33. 33.↵
    1. Bailey DG,
    2. Dresser GK,
    3. Urquhart BL,
    4. Freeman DJ,
    5. Arnold JM.
    Coffee-antihypertensive drug interaction: a hemodynamic and pharmacokinetic study with felodipine. Am J Hypertens 2016; 29: 1386-1393.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Myat T,
    2. Thu W.
    Coffee modify pharmacokinetics of acetaminophen. Environ Toxicol Pharmacol 2019; 7: 1091–1098.
    OpenUrl
  35. 35.↵
    1. Zafar S,
    2. Ashraf MM,
    3. Ali A,
    4. Aslam N,
    5. Ashraf A,
    6. Zafar S, et al.
    Effect of caffeine on anti-clotting activity of warfarin in healthy male albino rabbits. Pak J Pharm Sci 2018; 31: 611-616.
    OpenUrl
  36. 36.↵
    1. Belayneh A,
    2. Molla F.
    The effect of coffee on pharmacokinetic properties of drugs: a review. Biomed Res Int 2020; 2020: 7909703.
    OpenUrl
  37. 37.↵
    1. Craig CR,
    2. Stitzel RE.
    Modern Pharmacology with Clinical Applications, 5th edition. Philadelphia (PA): Lippincott Williams and Wilkins; 2004. p. 351
  38. 38.↵
    1. Boekema PJ,
    2. Lo B,
    3. Samsom M,
    4. Akkermans LM,
    5. Smout AJ.
    The effect of coffee on gastric emptying and oro-caecal transit time. Eur J Clin Invest 2000; 30: 129-134.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Hsu SJ,
    2. Lee FY,
    3. Wang SS,
    4. Hsin IF,
    5. Lin TY,
    6. Huang HC, et al.
    Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. Hepatology 2015; 61: 1672-1684.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Wu SE,
    2. Chen WL.
    Exploring the association between urine caffeine metabolites and urine flow rate: a cross-sectional study. Nutrients 2020; 12: 2803.
    OpenUrl
  41. 41.↵
    1. Alsabri SG,
    2. Mari WO,
    3. Younes S,
    4. Alsadawi MA,
    5. Oroszi TL.
    Kinetic and dynamic description of caffeine. J Caffeine Res 2018; 8: 3-9.
    OpenUrl
  42. 42.↵
    1. Mark PB,
    2. Stevens KK,
    3. Jardine AG.
    Electrolytes: Acid–Base Balance. Encyclopedia of Human Nutrition, 3rd edition. Cambridge (MA): Academic Press; 2013 p. 139-145.
  43. 43.↵
    1. Lawrence ML,
    2. Smith JR,
    3. Davies JA.
    Functional transport of organic anions and cations in the murine mesonephros. Am J.Physiol Renal Physiol 2018; 315: F130-F137.
    OpenUrl
  44. 44.↵
    1. Weiser T,
    2. Weigmann H.
    Effect of caffeine on the bioavailability and pharmacokinetics of an acetylsalicylic acid-paracetamol combination: results of a phase i study. Adv Ther 2019; 36: 597-607.
    OpenUrl
  45. 45.↵
    1. Gupta G,
    2. Krishna G,
    3. Chellappan DK,
    4. Gubbiyappa KS,
    5. Candasamy M,
    6. Dua K.
    Protective effect of pioglitazone, a PPARγ agonist against acetaminophen-induced hepatotoxicity in rats. Mol Cell Biochem 2014; 393: 223-228.
    OpenUrlCrossRef
  46. 46.
    1. Cachón AU,
    2. Quintal-Novelo C,
    3. Medina-Escobedo G,
    4. Castro-Aguilar G,
    5. Moo-Puc RE.
    Hepatopotective effect of low doses of caffeine on ccl4-induced liver damage in rats. J Diet Suppl 2017; 14: 158-172.
    OpenUrl
  47. 47.↵
    1. Ontawong, A,
    2. Boonphang O,
    3. Pasachan T,
    4. Duangjai A,
    5. Pongchaidecha A,
    6. Phatsara M et al.
    Hepatoprotective effect of coffee pulp aqueous extract combined with simvastatin against hepatic steatosis in high-fat diet-induced obese rats. J Funct.Foods 2019; 54: 568-577.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords